The Scientist

» FDA and cell & molecular biology

Most Recent

image: Image of the Day: Linked Out

Image of the Day: Linked Out

By | January 26, 2017

A study provides the first visual evidence that cytofilaments tunnel through a cell’s nucleus to the extracellular matrix.

0 Comments

image: Marijuana Research Still Stymied by Federal Laws

Marijuana Research Still Stymied by Federal Laws

By | January 23, 2017

US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.

1 Comment

image: Lipids Take the Lead in Metastasis

Lipids Take the Lead in Metastasis

By | January 20, 2017

Researchers find diverse ways that the molecules can regulate cancer’s spread.

0 Comments

image: Califf Vacates FDA’s Top Post

Califf Vacates FDA’s Top Post

By | January 20, 2017

Robert Califf steps down as FDA Commissioner as Donald Trump takes office.

0 Comments

image: Unknown Protein Structures Predicted

Unknown Protein Structures Predicted

By | January 19, 2017

Metagenomic sequence data boosts the power of protein modeling software to yield hundreds of new protein structure predictions.

0 Comments

image: Replication Complications

Replication Complications

By | January 18, 2017

An initiative to replicate key findings in cancer biology yields a preliminary conclusion: it’s difficult.

0 Comments

Clostridium botulinum produces a transcription factor that can aggregate and self-propagate a prion-like form, leading to genome-wide changes in gene expression in E. coli, according to a study.

1 Comment

A team of scientists was unable to replicate controversial, high-profile findings published in 2011.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

By | December 28, 2016

The oligonucleotide therapeutic will soon be available in the U.S.

0 Comments

Popular Now

  1. So You’ve Been Mistaken as a White Nationalist
  2. Opinion: We Need a Replacement for Beall’s List
  3. Your Body Is Teeming with Weed Receptors
    Features Your Body Is Teeming with Weed Receptors

    And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

  4. Doctors’ Advice to Finish Antibiotics Overlooks Resistance
AAAS